MED13L Gene Transposition of the Great Arteries Dextrolooped 1 NGS Genetic DNA Test
Comprehensive Genetic Testing for Congenital Heart Defects
The MED13L Gene Transposition of the Great Arteries Dextrolooped 1 NGS Genetic DNA Test represents a breakthrough in pediatric cardiology and genetic diagnostics. This advanced testing methodology provides crucial insights into one of the most complex congenital heart conditions affecting newborns and children worldwide. By examining the MED13L gene through Next-Generation Sequencing technology, healthcare providers can identify specific genetic mutations responsible for cardiac malformations, enabling early intervention and personalized treatment strategies.
What This Test Measures and Detects
This sophisticated genetic analysis specifically targets mutations in the MED13L gene, which plays a critical role in cardiac development during embryogenesis. The test utilizes state-of-the-art NGS technology to examine:
- Point mutations and single nucleotide variants in the MED13L gene
- Insertions and deletions affecting gene function
- Structural variations that may disrupt normal cardiac development
- Genetic markers associated with transposition of the great arteries
- Variants linked to dextro-looped cardiac malformations
Who Should Consider This Genetic Test
This comprehensive genetic screening is recommended for individuals and families experiencing:
- Newborns diagnosed with congenital heart defects, particularly transposition of the great arteries
- Children with unexplained cardiac abnormalities or murmurs
- Individuals with family history of congenital heart disease
- Patients with developmental delays and cardiac symptoms
- Families planning pregnancy with known cardiac genetic risks
- Individuals with dysmorphic features and cardiac concerns
Clinical Benefits of MED13L Genetic Testing
Undergoing this advanced genetic analysis provides numerous clinical advantages:
- Early Diagnosis: Enables prompt identification of genetic cardiac conditions
- Personalized Treatment: Guides customized medical and surgical interventions
- Family Planning: Provides crucial information for genetic counseling and reproductive decisions
- Proactive Monitoring: Allows for targeted surveillance and preventive care
- Comprehensive Understanding: Offers detailed insights into the genetic basis of cardiac conditions
Understanding Your Test Results
Our comprehensive genetic report provides clear, actionable information:
- Positive Result: Indicates the presence of MED13L gene mutations associated with cardiac defects, requiring specialized cardiology consultation
- Negative Result: Suggests no detected mutations in the MED13L gene, though other genetic factors may still be considered
- Variant of Uncertain Significance: Identifies genetic changes requiring further clinical correlation and monitoring
- Carrier Status: Determines if individuals carry mutations that could affect future generations
Test Pricing and Availability
| Test Component | Price (USD) |
|---|---|
| MED13L Gene Transposition of the Great Arteries Dextrolooped 1 NGS Genetic DNA Test | $700 |
| Special Discount Price | $500 |
Nationwide Testing Availability
We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our state-of-the-art facilities ensure accurate testing and rapid turnaround times of 3-4 weeks.
Pre-Test Requirements and Sample Collection
To ensure optimal testing accuracy, we require:
- Complete clinical history of the patient undergoing testing
- Genetic counseling session to document family pedigree
- Sample collection through blood draw, extracted DNA, or one drop of blood on FTA card
- Detailed information about affected family members
Take Control of Your Cardiac Health Today
Don’t wait to get the answers you need about congenital heart conditions. Our expert genetic counselors and pediatric cardiology specialists are ready to provide comprehensive testing and personalized guidance. Early genetic detection can significantly impact treatment outcomes and quality of life.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your MED13L genetic test consultation and take the first step toward understanding your cardiac health at the genetic level.
